Skip to Content
Merck
  • DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks.

DMAT, an inhibitor of protein kinase CK2 induces reactive oxygen species and DNA double strand breaks.

Oncology reports (2009-05-09)
Carolin C Schneider, Andrea Hessenauer, Claudia Götz, Mathias Montenarh
ABSTRACT

Elevated levels of protein kinase CK2 were found in tumour cells compared to normal cells. Thus, inhibition of CK2 kinase activity seems to be an attractive method to stop growth of cancer cells. Two drugs, namely tetrabromobenzotriazole, TBB, and 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, DMAT were found to specifically inhibit CK2 and to induce apoptosis in tumour cells. The aim of the present study was the elucidation of the mode of action of these two inhibitors in addition to the inhibition of CK2 activity. The decrease in CK2 kinase activity induced by both inhibitors was accompanied by a reduction in cell viability and induction of apoptosis. Most interestingly, we detected that DMAT in contrast to TBB induced reactive oxygen species, ROS and DNA-double-strand-breaks (DSBs). Thus, in addition to inhibition of CK2 one has to consider ROS and DSBs contributing to the induction of apoptosis by DMAT.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DMAT, ≥98% (HPLC)